The medication controls appetite
However, the decision to use tirzepatide should always be made in close consultation with healthcare providers, who can evaluate both the potential risks and benefits
FDA-approved non-GLP prescription appetite suppressants, used to safely assist with weight loss for over 40 years, can be an option if medically indicated
Primary Handling Editors: Ibrahim Javed and Benjamin Bessieres
Conclusions SM-PNPs exert a significant protective effect against HFD-induced hepatic damage and metabolic disturbances and represent a promising therapeutic strategy for metabolic dysfunction-associated steatotic liver disease (MASLD), potentially due to improved solubility, bioavailability, and sustained release in the nanoparticle formulation
Originally developed for type 2 diabetes, Semaglutide works by mimicking the effects of the natural hormone GLP-1